NPI: 1164876546 · BIRMINGHAM, AL 35211 · General Acute Care Hospital · NPI assigned 04/21/2016
Authorized official MILLER, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | MILLER, JOHN (SVP OF FINANCE) |
| NPI Enumeration Date | 04/21/2016 |
Other providers sharing the same authorized official: MILLER, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 17,216 | $336K |
| 2019 | 16,495 | $322K |
| 2020 | 12,571 | $249K |
| 2021 | 14,109 | $296K |
| 2022 | 17,812 | $619K |
| 2023 | 21,093 | $838K |
| 2024 | 8,258 | $463K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,935 | 3,077 | $936K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 16,457 | 14,433 | $931K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 17,711 | 15,712 | $570K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2,658 | 2,206 | $217K |
| 80053 | Comprehensive metabolic panel | 13,314 | 11,401 | $114K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 15,586 | 13,360 | $113K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5,102 | 4,276 | $53K |
| 71045 | Radiologic examination, chest; single view | 4,587 | 3,912 | $21K |
| 87088 | 2,292 | 1,925 | $19K | |
| 83690 | 2,734 | 2,331 | $15K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 379 | 357 | $15K |
| 70450 | Computed tomography, head or brain; without contrast material | 212 | 177 | $14K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 388 | 307 | $13K |
| 84484 | 1,445 | 1,083 | $12K | |
| 81001 | 3,580 | 3,267 | $11K | |
| 83735 | 1,693 | 1,414 | $10K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 228 | 166 | $9K |
| 81003 | 3,588 | 2,984 | $9K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 29 | 24 | $5K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 379 | 357 | $5K |
| 81025 | 1,847 | 1,690 | $5K | |
| 71046 | Radiologic examination, chest; 2 views | 417 | 400 | $4K |
| 84100 | 1,238 | 1,056 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,064 | 2,699 | $3K |
| 80047 | 358 | 323 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 237 | 208 | $2K |
| 87400 | 373 | 320 | $1K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 291 | 222 | $1K |
| 59025 | Fetal non-stress test | 244 | 144 | $1K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 28 | 28 | $1K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 41 | 13 | $876.20 |
| 83880 | 30 | 26 | $873.35 | |
| 83605 | 45 | 41 | $391.03 | |
| 97014 | 42 | 12 | $343.74 | |
| 85610 | 76 | 67 | $253.88 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 342 | 312 | $251.78 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 20 | 16 | $175.24 |
| 87430 | 13 | 12 | $144.36 | |
| 87186 | 13 | 12 | $101.10 | |
| 86850 | 20 | 16 | $63.45 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 14 | 12 | $61.20 |
| 86900 | 20 | 16 | $26.32 | |
| 85730 | 15 | 14 | $26.28 | |
| 86901 | 20 | 16 | $26.08 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 307 | 228 | $4.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 69 | 39 | $2.45 |
| J2704 | Injection, propofol, 10 mg | 217 | 167 | $2.40 |
| 36415 | Collection of venous blood by venipuncture | 37 | 27 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 33 | 26 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 18 | 14 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 1,754 | 1,262 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 14 | 12 | $0.00 |